Ruppert M, Van Hee R
Academic Surgical Centre Stuivenberg, General Centre Hospital Antwerp, University of Antwerp--UIA, Belgium.
Eur J Emerg Med. 2001 Sep;8(3):177-9. doi: 10.1097/00063110-200109000-00003.
Cardiac injuries can be life threatening. The possibility of late complications urges the practitioner to search for any evidence of cardiac trauma. But the diagnosis of cardiac injury remains difficult. Electrocardiography and cardiac enzyme determination are most widely used, because they are readily available. Many studies advocate creatine-kinase-MB (CK-MB) isoenzyme levels as a sensitive test for cardiac contusion. Others have discarded CK-MB testing as useless in trauma situations. An elevated CK-MB value in haemodynamically stable patients may confuse the individual practitioner. To better clarify its role we investigated the course of CK/CK-MB release after trauma, with no or only a very small chance of cardiac injury and compared it with patients with severe chest trauma having cardiac complications. A total of 25 trauma patients with only skeletal muscle injury were studied. Blood samples were taken during the first 4 days after trauma. These results were compared with those of a group of 91 consecutive patients with severe chest injury, including 10 with cardiac complications. Initial results in skeletal trauma patients were indicative of cardiac injury (CK > 5% of total CK and at least 20 U/l) in 10 patients. These findings were identical to those found in patients with severe chest injury having cardiac complications. CK/CK-MB tests are frequently positive after trauma without cardiac injury, even when selective criteria are used. The time each isoenzyme is released from muscle tissue after trauma greatly influences the outcome of the test. As this release does not occur at the same moment for each isoenzyme, the test result is very much time-dependent. As a result of these findings CK-MB testing tends to cause more confusion than clarification in trauma situations. We therefore eliminated CK-MB testing from our trauma protocol as a screening investigation for cardiac injury.
心脏损伤可能危及生命。晚期并发症的可能性促使医生寻找心脏创伤的任何证据。但心脏损伤的诊断仍然困难。心电图和心肌酶测定应用最为广泛,因为它们易于获得。许多研究主张将肌酸激酶同工酶MB(CK-MB)水平作为心脏挫伤的敏感检测指标。另一些人则认为在创伤情况下CK-MB检测毫无用处而摒弃了它。血流动力学稳定的患者中CK-MB值升高可能会让医生感到困惑。为了更好地阐明其作用,我们研究了创伤后无心脏损伤或仅有极小心脏损伤可能性的患者CK/CK-MB的释放过程,并将其与有心脏并发症的严重胸部创伤患者进行了比较。共研究了25例仅伴有骨骼肌损伤的创伤患者。在创伤后的前4天采集血样。将这些结果与一组91例连续的严重胸部损伤患者(包括10例有心脏并发症的患者)的结果进行比较。骨骼肌创伤患者最初的结果显示,10例患者存在心脏损伤(CK>总CK的5%且至少20 U/l)。这些发现与有心脏并发症的严重胸部损伤患者的发现相同。即使使用了选择性标准,创伤后无心脏损伤的患者CK/CK-MB检测也经常呈阳性。创伤后每种同工酶从肌肉组织中释放的时间对检测结果有很大影响。由于每种同工酶的释放并非同时发生,检测结果在很大程度上取决于时间。基于这些发现,在创伤情况下,CK-MB检测往往造成的困惑多于澄清作用。因此,我们在创伤诊疗方案中取消了CK-MB检测作为心脏损伤筛查检查的应用。